Shandong Weigao Group Medical Polymer Co (HKSE:01066) Change In Receivables : HK$0 Mil (TTM As of Dec. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Shandong Weigao Group Medical Polymer Co Change In Receivables?

Shandong Weigao Group Medical Polymer Co's change in receivables for the quarter that ended in Dec. 2024 was HK$0 Mil. It means Shandong Weigao Group Medical Polymer Co's Accounts Receivable stayed the same from Jun. 2024 to Dec. 2024 .

Shandong Weigao Group Medical Polymer Co's change in receivables for the fiscal year that ended in Dec. 2024 was HK$-349 Mil. It means Shandong Weigao Group Medical Polymer Co's Accounts Receivable increased by HK$349 Mil from Dec. 2023 to Dec. 2024 .

Shandong Weigao Group Medical Polymer Co's Accounts Receivable for the quarter that ended in Dec. 2024 was HK$6,490 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Shandong Weigao Group Medical Polymer Co's Days Sales Outstanding for the six months ended in Dec. 2024 was 171.95.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Shandong Weigao Group Medical Polymer Co's liquidation value for the six months ended in Dec. 2024 was HK$5,046 Mil.

Shandong Weigao Group Medical Polymer Co Change In Receivables Historical Data

The historical data trend for Shandong Weigao Group Medical Polymer Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Weigao Group Medical Polymer Co Change In Receivables Chart

Shandong Weigao Group Medical Polymer Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Receivables

Get a 7-Day Free Trial

-867.71

-318.76

-936.88

-190.16

-349.31

Shandong Weigao Group Medical Polymer Co Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Shandong Weigao Group Medical Polymer Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0 Mil.

Shandong Weigao Group Medical Polymer Co (HKSE:01066) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Shandong Weigao Group Medical Polymer Co's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	6489.715	/	6887.961	*	91
=	171.95

2. In Ben Graham's calculation of liquidation value, Shandong Weigao Group Medical Polymer Co's accounts receivable are only considered to be worth 75% of book value:

Shandong Weigao Group Medical Polymer Co's liquidation value for the quarter that ended in Dec. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	8884.962	-	10055.638	+	0.75 * 6489.715	+	0.5 * 2699.529
=	5,046

Shandong Weigao Group Medical Polymer Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Shandong Weigao Group Medical Polymer Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Shandong Weigao Group Medical Polymer Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shandong Weigao Group Medical Polymer Co Ltd (HKSE:01066) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

SHWGY:USA SHWGF:USA UK2:Germany

Address

No.1, Weigao Road, Torch Hi-tech Science Park, Shandong Province, Weihai, CHN

Website

https://www.weigaogroup.com

Shandong Weigao Group Medical Polymer Co Ltd functions in the healthcare sector in China. Its business mainly involves the research and development, production, and sale of single-use medical device products. The company's segments include Medical device products, Orthopaedic products, Interventional products, Pharma packaging products, Blood management products, and others. The company's products comprise consumables including infusion sets, syringes, medical needles, blood bags, prefilled syringes, wound management, blood sampling products; orthopedic materials, and blood purification consumables and equipment. The company operates in the People's Republic of China, the United States, Europe, the Middle East, and Africa, Asia, and others.

Executives

Wei Hai Wei Gao Guo Ji Yi Liao Tou Zi Kong Gu You Xian Gong Si
Wei Gao Ji Tuan You Xian Gong Si
Wellington Management Group Llp	2102 Investment manager
The Bank Of New York Mellon Corporation	2201 Interest of corporation controlled by you
Chen Xueli	2201 Interest of corporation controlled by you

Shandong Weigao Group Medical Polymer Co Headlines

No Headlines